[EN] FUSED RING INHIBITORS OF HEPATITIS C<br/>[FR] INHIBITEURS À NOYAUX FUSIONNÉS DE L'HÉPATITE C
申请人:PRESIDIO PHARMACEUTICALS INC
公开号:WO2010111534A1
公开(公告)日:2010-09-30
Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
本文提供了治疗丙型肝炎的化合物、药物组合和联合疗法。
FUSED RING INHIBITORS OF HEPATITIS C
申请人:Li Leping
公开号:US20120040962A1
公开(公告)日:2012-02-16
Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
本文提供了治疗丙型肝炎的化合物、药物组合和联合疗法。
Tricyclic fused ring inhibitors of hepatitis C
申请人:Li Leping
公开号:US08999967B2
公开(公告)日:2015-04-07
Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
本文提供了用于治疗丙型肝炎的化合物、药物组合和联合疗法。
Fused ring inhibitors of hepatitis C
申请人:Li Leping
公开号:US09150554B2
公开(公告)日:2015-10-06
Provided herein are compounds of Formula I, pharmaceutical compositions comprising the same, and combination therapies comprising the same for treatment of hepatitis C.